Bellicum Pharmaceuticals Inc
(OTCPK:BLCM)
$0.33
-0.292[-46.95%]
Last update: 2:42PM (Delayed 15-Minutes)
Get Real Time Here
Open-Close-
Vol / Avg.18.552K / 26.835KMkt Cap3.134M
Day Range- - -52 Wk Range0.225 - 1.500

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -

Bellicum Pharmaceuticals Stock (OTC:BLCM), Key Statistics

Bellicum Pharmaceuticals Stock (OTC: BLCM) analysis, key statistics.

Valuation Measures
Enterprise Value
-43M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
6.54
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-290.53%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-2.3
Tangible Book value per share
-2.3
Total Liabilities (Quarterly)
30.6M
Total Assets
8.7M
Total Liabilities
3.5M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -